Isabella Bank Corporation Reports Fourth Quarter 2024 Results
MT. PLEASANT, Mich., Jan. 30, 2025 /PRNewswire/ — Isabella Bank Corporation (OTCQX: ISBA) (the “Company” or “we”) reported fourth quarter 2024 net income of $4.0 million, or $0.54 per diluted share, an increase compared to $3.8 million, or $0.51 per diluted share in the
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Kyverna To Contact Him Directly To Discuss Their Options If you purchased or acquired securities investing Kyverna common stock pursuant and/or traceable to the Offering Documents
VISTA Eye Specialist Honored as One of Asia’s Top Private Hospitals by Newsweek for 2025
PETALING JAYA, Malaysia, Jan. 31, 2025 /PRNewswire/ — VISTA Eye Specialist (VISTA) is proud to announce its inclusion among Asia’s Top Private Hospitals for 2025, as recognized by the prestigious Newsweek magazine. This accolade highlights VISTA’s unwavering dedication to providin
New Black History Month stamp features Marie Joseph Angélique
Accused of a crime she denied doing, Angélique’s story sheds light on the history of – and resistance to – enslavement in what is now Canada MONTRÉAL, Jan. 30, 2025 /CNW/ – Canada Post today unveiled its 2025 Black History Month stamp featuring Marie Joseph Angélique. Her harrowin
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management SILVER SPRING, Md., Jan. 30, 2025 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets,
Arvore Declares Its December Normal Distribution – Annualized 9.5%
CALGARY, AB, Jan. 30, 2025 /CNW/ – Arvore Partners LP (“Arvore”) is pleased to announce that it has declared its December monthly distribution at an annualized rate of 9.5% for Series W and Series A. The distribution will be paid to investors on January 31, 2025. Arvore remains c
Statement by the Minister of Transport on the mid-air collision involving United States military Black Hawk helicopter and American Airlines flight 5342 in Washington
OTTAWA, ON, Jan. 30, 2025 /CNW/ – The Honourable Anita Anand, Minister of Transport and Internal Trade, today offered the following statement concerning the incident involving a United States military Black Hawk helicopter and American Airlines flight 5342, a Bombardier CRJ-700, in Washington
Oakland-Area High School Seniors Graduate from Racial Equity Financial Education Program with New-Found Knowledge, $8,000 College Scholarships
Partners PG&E, PG&E Foundation, UC Berkeley and Mills College at Northeastern to Celebrate Graduates of Program Targeting Wealth Gap OAKLAND, Calif., Jan. 30, 2025 /PRNewswire/ — Twenty-three high school students will receive $8,000 scholarships upon graduating from the PG&E Econom
Youxin Technology Ltd Reports Financial Results for Fiscal Year 2024
GUANGZHOU, China, Jan. 30, 2025 /PRNewswire/ — Youxin Technology Ltd (Nasdaq: YAAS) (the “Company” or “Youxin Technology”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digit
Nexpoint Residential Trust Announces 2024 Dividend Income Tax Treatment
DALLAS, Jan. 30, 2025 /PRNewswire/ — NexPoint Residential Trust, Inc. (“NXRT” or the “Company”) (NYSE: NXRT) announced today the final income allocations of the Company’s 2024 dividend distributions on its common stock. The final income allocations as they will be
